Funding for this research was provided by:
Internationale Stichting Alzheimer Onderzoek (15040)
Received: 21 April 2020
Accepted: 13 August 2020
First Online: 26 August 2020
Ethics approval and consent to participate
: The SCHIP study was approved by the institutional review board (CMO, Commissie Mensgebonden Onderzoek, Region Arnhem-Nijmegen, NL55712.091.16, file number 2016-2337) and performed in accordance with good clinical practice guidelines and the world medical associations code of ethics (Declaration of Helsinki). Written informed consent was obtained from all participants after they received detailed study information. Participants received a stipend of 50 euros for participating; travel costs were compensated.
: Not applicable.
: The authors declare that they have no competing interests.